Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data

Objective Serious infection remains a concern when prescribing immune-modulatory drugs for immune-mediated inflammatory diseases. The ‘summary of product characteristics’ (SmPCs) provide information on adverse events for example, infections, from clinical trials and postmarketing pharmacovigilance.T...

Full description

Bibliographic Details
Main Authors: Catherine Smith, Andrew Cope, Elena Nikiphorou, Mrinalini Dey, James Galloway, Kimme L Hyrich, Katie Bechman, Sizheng Zhao
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002621.full

Similar Items